DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1

Experimental Cell Research

Volumn 315, Issue 17, 2009, Pages 2941-2952

  Lerner, Mikael ^a   Harada, Masako ^a   Lovén, Jakob ^a   Castro, Juan ^a   Davis, Zadie ^b   Oscier, David ^b   Henriksson, Marie ^a   Sangfelt, Olle ^a   Grandér, Dan ^a   Corcoran, Martin M ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

Author keywords

Chronic lymphocytic leukemia; Cyclins; Host gene; miR 15a; miR 16 1; Myc

Indexed keywords

CYCLIN D1; CYCLIN E1; CYCLINE; MICRORNA; MYC PROTEIN; ONCOPROTEIN; PROTEIN DLEU2; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER GENETICS; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL STRAIN HEK293; CELL STRAIN MCF 7; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SOLID TUMOR;

EID: 70349456537     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.07.001     Document Type: Article

References (52)

1. Riley T., Sontag E., Chen P., and Levine A. Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell Biol. 9 (2008) 402-412
2. Halbeisen R.E., Galgano A., Scherrer T., and Gerber A.P. Post-transcriptional gene regulation: from genome-wide studies to principles. Cell. Mol. Life Sci. 65 (2008) 798-813
3. Stilgenbauer S., Lichter P., and Dohner H. Genetic features of B-cell chronic lymphocytic leukemia. Rev. Clin. Exp. Hematol. 4 (2000) 48-72
4. Kohlhammer H., Schwaenen C., Wessendorf S., Holzmann K., Kestler H.A., Kienle D., Barth T.F., Moller P., Ott G., Kalla J., Radlwimmer B., Pscherer A., Stilgenbauer S., Dohner H., Lichter P., and Bentz M. Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions. Blood 104 (2004) 795-801
5. Bigoni R., Cuneo A., Milani R., Roberti M.G., Bardi A., Rigolin G.M., Cavazzini F., Agostini P., and Castoldi G. Secondary chromosome changes in mantle cell lymphoma: cytogenetic and fluorescence in situ hybridization studies. Leuk. Lymphoma 40 (2001) 581-590
6. Harrison C.J., Mazzullo H., Cheung K.L., Gerrard G., Jalali G.R., Mehta A., Osier D.G., and Orchard K.H. Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results. Br. J. Haematol. 120 (2003) 944-952
7. Ogawara K., Miyakawa A., Shiba M., Uzawa K., Watanabe T., Wang X.L., Sato T., Kubosawa H., Kondo Y., and Tanzawa H. Allelic loss of chromosome 13q14.3 in human oral cancer: correlation with lymph node metastasis. Int. J. Cancer 79 (1998) 312-317
8. Brookman-Amissah N., Nariculam J., Freeman A., Willamson M., Kirby R.S., Masters J.R., and Feneley M.R. Allelic imbalance at 13q14.2 approximately q14.3 in localized prostate cancer is associated with early biochemical relapse. Cancer Genet. Cytogenet. 179 (2007) 118-126
9. Liu Y., Corcoran M., Rasool O., Ivanova G., Ibbotson R., Grander D., Iyengar A., Baranova A., Kashuba V., Merup M., Wu X., Gardiner A., Mullenbach R., Poltaraus A., Hultstrom A.L., Juliusson G., Chapman R., Tiller M., Cotter F., Gahrton G., Yankovsky N., Zabarovsky E., Einhorn S., and Oscier D. Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia. Oncogene 15 (1997) 2463-2473
10. Kapanadze B., Makeeva N., Corcoran M., Jareborg N., Hammarsund M., Baranova A., Zabarovsky E., Vorontsova O., Merup M., Gahrton G., Jansson M., Yankovsky N., Einhorn S., Oscier D., Grander D., and Sangfelt O. Comparative sequence analysis of a region on human chromosome 13q14, frequently deleted in B-cell chronic lymphocytic leukemia, and its homologous region on mouse chromosome 14. Genomics 70 (2000) 327-334
11. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., Aldler H., Rattan S., Keating M., Rai K., Rassenti L., Kipps T., Negrini M., Bullrich F., and Croce C.M. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 15524-15529
12. Linsley P.S., Schelter J., Burchard J., Kibukawa M., Martin M.M., Bartz S.R., Johnson J.M., Cummins J.M., Raymond C.K., Dai H., Chau N., Cleary M., Jackson A.L., Carleton M., and Lim L. Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol. Cell. Biol. 27 (2007) 2240-2252
13. Sambrook J., and Russell D. Molecular Cloning: A Laboratory Manual. 3rd edition (2001), Cold Spring Harbour Laboratory Press, Cold Spring Harbour, New York
14. Boyd K.E., Wells J., Gutman J., Bartley S.M., and Farnham P.J. c-Myc target gene specificity is determined by a post-DNA binding mechanism. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13887-13892
15. Wendel-Hansen V., Sallstrom J., De Campos-Lima P.O., Kjellstrom G., Sandlund A., Siegbahn A., Carlsson M., Nilsson K., and Rosen A. Epstein-Barr virus (EBV) can immortalize B-cll cells activated by cytokines. Leukemia 8 (1994) 476-484
16. Lerner M., Corcoran M., Cepeda D., Nielsen M.L., Zubarev R., Ponten F., Uhlen M., Hober S., Grander D., and Sangfelt O. The RBCC gene RFP2 (Leu5) encodes a novel transmembrane E3 ubiquitin ligase involved in ERAD. Mol. Biol. Cell. 18 (2007) 1670-1682
17. Kim Y.K., and Kim V.N. Processing of intronic microRNAs. Embo J. 26 (2007) 775-783
18. Chang T.C., Yu D., Lee Y.S., Wentzel E.A., Arking D.E., West K.M., Dang C.V., Thomas-Tikhonenko A., and Mendell J.T. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat. Genet. 40 (2008) 43-50
19. Pajic A., Spitkovsky D., Christoph B., Kempkes B., Schuhmacher M., Staege M.S., Brielmeier M., Ellwart J., Kohlhuber F., Bornkamm G.W., Polack A., and Eick D. Cell cycle activation by c-myc in a Burkitt lymphoma model cell line. Int. J. Cancer 87 (2000) 787-793
20. Barski A., Cuddapah S., Cui K., Roh T.Y., Schones D.E., Wang Z., Wei G., Chepelev I., and Zhao K. High-resolution profiling of histone methylations in the human genome. Cell 129 (2007) 823-837
21. Huang J.C., Babak T., Corson T.W., Chua G., Khan S., Gallie B.L., Hughes T.R., Blencowe B.J., Frey B.J., and Morris Q.D. Using expression profiling data to identify human microRNA targets. Nat. Methods 4 (2007) 1045-1049
22. Won K.A., and Reed S.I. Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. Embo J. 15 (1996) 4182-4193
23. Strohmaier H., Spruck C.H., Kaiser P., Won K.A., Sangfelt O., and Reed S.I. Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 413 (2001) 316-322
24. Reed S.I. Ratchets and clocks: the cell cycle, ubiquitylation and protein turnover. Nat. Rev. Mol. Cell Biol. 4 (2003) 855-864
25. Liang Y., Ridzon D., Wong L., and Chen C. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 8 (2007) 166
26. Bonci D., Coppola V., Musumeci M., Addario A., Giuffrida R., Memeo L., D'Urso L., Pagliuca A., Biffoni M., Labbaye C., Bartucci M., Muto G., Peschle C., and De Maria R. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat. Med. 14 (2008) 1271-1277
27. Blenkiron C., Goldstein L.D., Thorne N.P., Spiteri I., Chin S.F., Dunning M.J., Barbosa-Morais N.L., Teschendorff A.E., Green A.R., Ellis I.O., Tavare S., Caldas C., and Miska E.A. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol. 8 (2007) R214
28. Xia L., Zhang D., Du R., Pan Y., Zhao L., Sun S., Hong L., Liu J., and Fan D. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int. J. Cancer 123 (2008) 372-379
29. Amaral F.C., Torres N., Saggioro F., Neder L., Machado H.R., Silva Jr. W.A., Moreira A.C., and Castro M. MicroRNAs differentially expressed in ACTH-secreting pituitary tumors. J. Clin. Endocrinol. Metab. 94 (2009) 320-323
30. Chung E.Y., Dews M., Cozma D., Yu D., Wentzel E.A., Chang T.C., Schelter J.M., Cleary M.A., Mendell J.T., and Thomas-Tikhonenko A. c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA cluster. Cancer Biol. Ther. 7 (2008)
31. Corcoran M.M., Hammarsund M., Zhu C., Lerner M., Kapanadze B., Wilson B., Larsson C., Forsberg L., Ibbotson R.E., Einhorn S., Oscier D.G., Grander D., and Sangfelt O. DLEU2 encodes an antisense RNA for the putative bicistronic RFP2/LEU5 gene in humans and mouse. Genes Chromosomes Cancer 40 (2004) 285-297
32. Mertens D., Philippen A., Ruppel M., Allegra D., Bhattacharya N., Tschuch C., Wolf S., Idler I., Zenz T., and Stilgenbauer S. Chronic lymphocytic leukemia and 13q14: miRs and more. Leuk. Lymphoma 50 (2009) 502-505
33. Kalachikov S., Migliazza A., Cayanis E., Fracchiolla N.S., Bonaldo M.F., Lawton L., Jelenc P., Ye X., Qu X., Chien M., Hauptschein R., Gaidano G., Vitolo U., Saglio G., Resegotti L., Brodjansky V., Yankovsky N., Zhang P., Soares M.B., Russo J., Edelman I.S., Efstratiadis A., Dalla-Favera R., and Fischer S.G. Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia. Genomics 42 (1997) 369-377
34. Ouillette P., Erba H., Kujawski L., Kaminski M., Shedden K., and Malek S.N. Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14. Cancer Res. 68 (2008) 1012-1021
35. Cimmino A., Calin G.A., Fabbri M., Iorio M.V., Ferracin M., Shimizu M., Wojcik S.E., Aqeilan R.I., Zupo S., Dono M., Rassenti L., Alder H., Volinia S., Liu C.G., Kipps T.J., Negrini M., and Croce C.M. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 13944-13949
36. Karaa Z.S., Iacovoni J.S., Bastide A., Lacazette E., Touriol C., and Prats H. The VEGF IRESes are differentially susceptible to translation inhibition by miR-16. Rna 15 (2009) 249-254
37. Shanmugam N., Reddy M.A., and Natarajan R. Distinct roles of heterogeneous nuclear ribonuclear protein K and microRNA-16 in cyclooxygenase-2 RNA stability induced by S100b, a ligand of the receptor for advanced glycation end products. J. Biol. Chem. 283 (2008) 36221-36233
38. Jing Q., Huang S., Guth S., Zarubin T., Motoyama A., Chen J., Di Padova F., Lin S.C., Gram H., and Han J. Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 120 (2005) 623-634
39. Deshpande A., Sicinski P., and Hinds P.W. Cyclins and cdks in development and cancer: a perspective. Oncogene 24 (2005) 2909-2915
40. Dickson C., Fantl V., Gillett C., Brookes S., Bartek J., Smith R., Fisher C., Barnes D., and Peters G. Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer. Cancer Lett. 90 (1995) 43-50
41. Jares P., Colomer D., and Campo E. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat. Rev. Cancer 7 (2007) 750-762
42. Akhoondi S., Sun D., von der Lehr N., Apostolidou S., Klotz K., Maljukova A., Cepeda D., Fiegl H., Dafou D., Marth C., Mueller-Holzner E., Corcoran M., Dagnell M., Nejad S.Z., Nayer B.N., Zali M.R., Hansson J., Egyhazi S., Petersson F., Sangfelt P., Nordgren H., Grander D., Reed S.I., Widschwendter M., Sangfelt O., and Spruck C. FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res. 67 (2007) 9006-9012
43. Tyers M., and Jorgensen P. Proteolysis and the cell cycle: with this RING I do thee destroy. Curr. Opin. Genet. Dev. 10 (2000) 54-64
44. Lin D.I., Barbash O., Kumar K.G., Weber J.D., Harper J.W., Klein-Szanto A.J., Rustgi A., Fuchs S.Y., and Diehl J.A. Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex. Mol. Cell 24 (2006) 355-366
45. Ivanovska I., Ball A.S., Diaz R.L., Magnus J.F., Kibukawa M., Schelter J.M., Kobayashi S.V., Lim L., Burchard J., Jackson A.L., Linsley P.S., and Cleary M.A. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol. Cell. Biol. 28 (2008) 2167-2174
46. le Sage C., Nagel R., Egan D.A., Schrier M., Mesman E., Mangiola A., Anile C., Maira G., Mercatelli N., Ciafre S.A., Farace M.G., and Agami R. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. Embo J. 26 (2007) 3699-3708
47. Galardi S., Mercatelli N., Giorda E., Massalini S., Frajese G.V., Ciafre S.A., and Farace M.G. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J. Biol. Chem. 282 (2007) 23716-23724
48. Chen R.W., Bemis L.T., Amato C.M., Myint H., Tran H., Birks D.K., Eckhardt S.G., and Robinson W.A. Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma. Blood 112 3 (2008) 822-829
49. Liu Q., Fu H., Sun F., Zhang H., Tie Y., Zhu J., Xing R., Sun Z., and Zheng X. miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res. 36 (2008) 5391-5404
50. Mao D.Y., Watson J.D., Yan P.S., Barsyte-Lovejoy D., Khosravi F., Wong W.W., Farnham P.J., Huang T.H., and Penn L.Z. Analysis of Myc bound loci identified by CpG island arrays shows that Max is essential for Myc-dependent repression. Curr. Biol. 13 (2003) 882-886
51. Matsushime H., Roussel M.F., Ashmun R.A., and Sherr C.J. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65 (1991) 701-713
52. Bouchard C., Thieke K., Maier A., Saffrich R., Hanley-Hyde J., Ansorge W., Reed S., Sicinski P., Bartek J., and Eilers M. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. Embo J. 18 (1999) 5321-5333